CRUK | Research and trials | Professor Tim Bishop -- aspirin and bowel cancer

Professor Tim Bishop, chair of the Cancer Research UK Leeds Centre, discusses the results of the CAPP2 trial which found that aspirin halves the risk of bowel cancer in people with Lynch syndrome. The study is published today in the Lancet.